Proactive Investor's  Instablog

Proactive Investor
Send Message
Proactiveinvestors is a leading multimedia news organization, investor portal and events management business with offices in New York, Sydney, Toronto and London. Proactiveinvestors operates five financial websites in four languages providing breaking news, comment and analysis on hundreds of... More
My company:
My blog:
  • Catalyst Pharmaceutical sees positive efficacy results from trials with epilepsy drug 0 comments
    Nov 1, 2010 2:23 PM | about stocks: CPRX

    Catalyst Pharmaceutical Partners (Nasdaq:CPRX) announced on Monday positive results from a series of trials for CPP-115, a drug in development for the treatment of epilepsy.

    Catalyst said that CPP-115 was found to be significantly safer visually than vigabatrin, the only other known and commercially available comparable treatment.

    In a trial with treated rats exposed for 90 days to CPP-115, vigabatrin and placebo, CPP-115 was found to reduce seizures, as evaluated by the National Institute of Health's Anticonvulsant Screening Program, at lower doses than vigabatrin with substantially less retinal damage.

    "We are extremely pleased that CPP-115 demonstrated a major improvement in visual safety compared to vigabatrin. The potential risk of peripheral vision loss from vigabatrin has been an important concern among patients and their physicians," said Catalyst CEO Patrick J. McEnany.

    During the study, the results also indicated that CPP-115 could be used for drug-related addictions, with effects observed at doses more than 100 times lower than those needed by vigabatrin, the company said.

    In addition, the new compound showed that it did not inhibit any key metabolic enzymes in the body, ensuring that there are no unintended side effects.

    The company now expects to begin the remaining studies necessary to file an IND in the third quarter of next year.

    CPP-115 is the lead compound being developed by Catalyst under its license agreement with Northwestern University.

    Disclosure: no position
    Stocks: CPRX
Back To Proactive Investor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.